RACHEL PIPPENGER: Open Payments
NPI 1164893616 · NAPPANEE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 17 payments from 8 companies in 2025. Trend: 2023 $846 · 2024 $461 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| PFIZER INC. | 3 | $44 |
| ABBVIE INC. | 2 | $40 |
| Exact Sciences Corporation | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, NURTEC ODT, BREZTRI, VRAYLAR, Cologuard Collection Kit, CAPLYTA, Ozempic.
Industry payments across IN — which companies pay providers there.
